Human trials are limited and methodologically mixed
Tumor Growth, Circadian Genes, and Radiation Response Epithalon has been evaluated in several experimental oncology models: In rodent tumor models, repeated Epithalon administration has been associated with slower tumor growth kinetics and reduced incidence of metastasis under specific conditions
Exposure risks to fetal development or infant health remain unstudied
Principal Investigator on A Randomized, Double-blind, Multicentre, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. Principal Investigator on A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNR. (Janssen)
A peptide-powered serum built for balance, not overwhelm